Novel Psychoactive Substances
Classification, Pharmacology and Toxicology
2nd Edition
Published on 9. September 2021
Book
Hardback
554 pages
978-0-12-818788-3 (ISBN)
Description
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters.
Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.
Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.
More details
Edition
2nd edition
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 239 mm
Width: 196 mm
Thickness: 32 mm
Weight
1310 gr
ISBN-13
978-0-12-818788-3 (9780128187883)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Paul I. Dargan | David M. Wood
Novel Psychoactive Substances
Classification, Pharmacology and Toxicology
E-Book
09/2021
2nd Edition
Academic Press
€109.00
Available for download
Previous edition
Paul I. Dargan | David M. Wood
Novel Psychoactive Substances
Classification, Pharmacology and Toxicology
Book
09/2013
Academic Press
€96.50
Shipment within 15-20 days
Persons
Professor Dargan and Dr Wood are both expert advisors on novel psychoactive substances to expert bodies in the UK (Advisory Council on the Misuse of Drugs, ACMD), Europe (European Monitoring Centre for Drugs and Drug Addiction, EMCDDA) and Worldwide (United Nations Office on Drugs and Crime, UNODC). They run a clinical service managing patients with acute drug toxicity, and have a clinical and research interest in novel psychoactive substances. They publish widely in this field and have both been invited to give keynote lectures at International meetings on this topic. David Wood is a Consultant Physician and Clinical Toxicologist at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Content
I. Background
1. Legal Classification and International Systems for Monitoring Novel Psychoactive Substances
2. Availability and Supply of Novel Psychoactive Substances
3. Prevalence of Use of Novel Psychoactive Substances
4. Pharmacological Profiling of Novel Psychoactive Substances
5. Novel methods of NPS detection and data triangulation
6. Social issues in the use of novel psychoactive substances
7. General management of the patient with Novel Psychoactive Substance Toxicity
8. Addiction and treatment of Novel Psychoactive Substance dependence
II. Analytical Techniques
9. Analytical techniques for the detection of novel psychoactive substances and their metabolites
III. Individual Novel Psychoactive Substances
10. Synthetic Amphetamines including novel MDMA analogues
11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens
12. 1-Benzylpiperazine and other Piperazine-based stimulants
13. Cathinones
14. Arylcyclohexamines
15. Synthetic cannabinoids
16. Novel opioids
17. Novel benzodiazepines
18. Tryptamines
1. Legal Classification and International Systems for Monitoring Novel Psychoactive Substances
2. Availability and Supply of Novel Psychoactive Substances
3. Prevalence of Use of Novel Psychoactive Substances
4. Pharmacological Profiling of Novel Psychoactive Substances
5. Novel methods of NPS detection and data triangulation
6. Social issues in the use of novel psychoactive substances
7. General management of the patient with Novel Psychoactive Substance Toxicity
8. Addiction and treatment of Novel Psychoactive Substance dependence
II. Analytical Techniques
9. Analytical techniques for the detection of novel psychoactive substances and their metabolites
III. Individual Novel Psychoactive Substances
10. Synthetic Amphetamines including novel MDMA analogues
11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens
12. 1-Benzylpiperazine and other Piperazine-based stimulants
13. Cathinones
14. Arylcyclohexamines
15. Synthetic cannabinoids
16. Novel opioids
17. Novel benzodiazepines
18. Tryptamines